Abstract
Prostatic disease continues to present clinicians with challenges. Giant strides have been made in the medical and surgical management of BPH; however, many fundamental questions about pathogenesis, progression, and treatment efficacy remain unanswered. Prostate cancer also continues to be an area in which progress is needed despite major recent advancements. Numerous debates that include the value of PSA screening and appropriate roles for each of the numerous therapeutic modalities await resolution. For millions of patients who suffer from prostatitis, a major breakthrough is yet to come. Current treatment regimens for this important and prevalent clinical entity remain ineffective at best.
| Original language | English |
|---|---|
| Pages (from-to) | 649-663 |
| Number of pages | 15 |
| Journal | Radiologic Clinics of North America |
| Volume | 44 |
| Issue number | 5 |
| DOIs | |
| State | Published - Sep 2006 |